CNTB · Connect Biopharma Holdings Ltd
$2.55
+0.01 (+0.39%)
At close · Aug 14
Market Cap
$160.58M
Shares
62.97M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kan Chen | member of the Board of Directors | Resigned | 2025-12-23 |
| James A. Schoeneck | director | Appointed | 2025-07-22 |
Key facts
CIK
1835268
CUSIP
G23549101
13F (30d)
53 filings
53 filers
Visit website
Investor relations